Skip to main content

Felicia Williams

Equibles does not estimate personal net worth.

Get an email with a short summary when Neogenomics Inc publishes a filing, an earnings call transcript or a press release.

Get NEO alerts

About Felicia Williams

Felicia Williams is recorded as Board Member at Neogenomics Inc (NEO) and CFO at Macy's, Inc. (M). The newest filing on record that lists Felicia Williams as Board Member at Neogenomics Inc (NEO) is dated April 6, 2026. The newest filing on record that lists Felicia Williams as CFO at Macy's, Inc. (M) is dated April 6, 2021. Neogenomics Inc reported in an 8-K filed May 22, 2026 that Felicia Williams was appointed member of the Board of Directors, effective May 21, 2026. Neogenomics Inc reported in an 8-K filed May 27, 2025 that Felicia Williams was appointed member of the Board of Directors, effective May 22, 2025. Neogenomics Inc reported in an 8-K filed November 5, 2024 that Felicia Williams was appointed member of the Board, the Company's Audit and Finance Committee (the "Audit Committee") and the Company's Nominating and Corporat, effective November 1, 2024. Felicia Williams has spoken on 2 earnings calls across 1 company, most recently for Macy's, Inc. on August 31, 2019. Macy's, Inc. is classified in the Department Stores industry within the Consumer Cyclical sector. Neogenomics Inc is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at Macy's, Inc. includes Tony Spring (CEO and Board Member), Adrian Mitchell (CFO), Adrian V. Mitchell (CFO and COO) and 7 others.

“The election of Lynn A. Tetrault, Dr. Marjorie C. Green, Dr. Neil Gunn, Stephen M. Kanovsky, Michael A. Kelly, John P. Kenny, David B. Perez, Felicia Williams and Anthony P. Zook to serve as members of the Board of Directors until the next succeeding annual meeting of stockholders or until his or her successor has been duly elected and qualified.”
Neogenomics Inc Form 8-K, filed May 22, 2026 · Read the filing
“The election of Lynn A. Tetrault, Elizabeth A. Floegel, Dr. Neil Gunn, Dr. Alison L. Hannah, Stephen M. Kanovsky, Michael A. Kelly, David B. Perez, Felicia Williams and Anthony P. Zook to serve as members of the Board of Directors until the next succeeding annual meeting of stockholders or until his or her successor has been duly elected and qualified.”
Neogenomics Inc Form 8-K, filed May 27, 2025 · Read the filing

Felicia Williams on recent calls

“As Jeff said, the second quarter closed stronger than we anticipated and this strength happened across all three brands; Macy's, Bloomingdale's, and Bluemercury.”
CFO, Macy's, Inc. Q2 FY2020 Earnings Call ·
“As Jeff noted, we are reporting our full first quarter financial results, inclusive of impairment, which were excluded from our previously reported results. I will touch on these impairment charges in just a moment.”
CFO, Macy's, Inc. Q1 FY2020 Earnings Call ·

Affiliation history

  • Neogenomics Inc (NEO)

    Board Member

    Proxy statement

    Current

    Start not stated–present

    Last confirmed April 6, 2026

  • Macy's, Inc. (M)

    CFO

    Proxy statement

    Current

    Start not stated–present

    Last confirmed April 6, 2021

Company network

Leadership on record at Macy's, Inc.

Leadership on record at Neogenomics Inc

Recent activity